AKT1 and non-small cell lung carcinoma: miR-135a promoted cell apoptosis and inhibited cell proliferation, migration, invasion, and tumor angiogenesis by targeting the IGF-1 gene through the IGF-1/PI3K/Akt signaling pathway in non-small cell lung cancer (NSCLC) (122).